There are five different dose strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
They help: Stimulate insulin production after meals (lowering blood sugar) Slow gastric emptying (so patients feel full longer) Reduce appetite through direct effects on the brain While originally approved for type 2 diabetes, some GLP1s, such as Saxenda, Wegovy and Zepbound, carry FDA approval for weight loss in adults with a BMI of 30 or more, or 27 with other health issues like high blood pressure or cholesterol
In individuals with overweight or obesity and type 2 diabetes, semaglutide 2.4 mg resulted in a mean weight loss of 9.6% compared to 3.4% with placebo in 68 weeks
Patients receive a baseline metabolic profile that helps providers tailor medication selection and dosing
GLP-1 Agonists in Type 2 Diabetes Management Managing type 2 diabetes is often complex, involving lifestyle changes, blood sugar monitoring, and medications
Achieve a More Defined You: Bring out the detail youve been looking for with SteelFits advanced skin-firming formula